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Abstract
Previously, we reported successful immortalisation following hTERT introduction in primary human fibroblasts, strain VH25. Since one
subclone in that study developed some abnormalities, we decided to study eight additional independent immortalised clones to get an indication of
the frequency and type of abnormalities that develop after hTERT-mediated immortalisation. We show that although some cell lines can maintain a
normal phenotype for 500 population doublings (PDs), in four clones after 150–300 PDs changes developed in basal and radiation-induced p53 and
p21WAF-1,CIP-1 levels. Our experiments demonstrate that, after prolonged culture, cells with abnormalities in cell cycle control parameters can take
over the population. This calls for caution when working with hTERT-immortalised cells in vitro as well as in vivo.
# 2005 Elsevier Ireland Ltd. All rights reserved.
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Mechanisms of Ageing and Development 127 (2006) 85–87After the initial demonstration that the introduction of
human telomerase (hTERT) in normal human cells is sufficient
to immortalise them (Bodnar et al., 1998), a number of reports
have been published on the effects of immortalising cells with
hTERT. No changes in phenotype were reported, and hTERT
immortalised cells appeared to provide an infinite supply of
normal human cells (Bodnar et al., 1998; Jiang et al., 1999;
Morales et al., 1999; Nakamura et al., 2002). We recently
reported our results with hTERT immortalised human foreskin
fibroblasts (VH25) in response to ionising radiation (Kampinga
et al., 2004) and showed that these cells retained their normal
phenotype for the first few 100 population doublings (PDs)
while VH25 fibroblasts senesce at PD 40–45. However, we
observed one subclone at PD 310 which showed tetraploidy and
altered response in radiation sensitivity (Kampinga et al.,
2004). To further investigate the frequency of occurrence of an
abnormal phenotype, we continued to grow seven additional
independent hTERT immortalised clones during 80–150
weeks, corresponding to 250–550 PDs. At several time points
growth characteristics and cell cycle parameters were analysed* Corresponding author.
E-mail address: m.h.k.linskens@rug.nl (M.H.K. Linskens).
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doi:10.1016/j.mad.2005.08.008(see Table 1). As we reported earlier, during the first 100 PDs no
alterations compared to the primary cells (VH25) were seen in
terms of radiosensitivity (clonogenic assay), DNA double-
strand break repair (as measured by PFGE), radiation-induced
increases in p53 and p21 expression, and the G1/S and G2/M
cell cycle checkpoints. However, after 150–300 PDs four out of
eight independent immortal clones did show changes in some of
these parameters. Three cell lines showed changes in p53 and
p21WAF-1,CIP-1 expression (Fig. 1; Group B) with or without
changes in ploidy (Table 1; Group B). One other line became
tetraploid without obvious changes in p53 and p21WAF-1,CIP-1
expression (Table 1; Group C). The other four clones (Group A)
still retained the characteristics of the wild type cells after 300–
500 PDs, except for growth rates which increased for all eight
clones from 2 to 3 PDs/week to about 4 PDs/week (Fig. 2).
Although there is no significant difference in growth rate seen
between the normal clones and the clones which developed
abnormalities in cell cycle control (Group B) or ploidy (Group
C) we observed an increase in growth rate before the onset of
detectable abnormalities. We previously determined (Kam-
pinga et al., 2004) that the mitotic index for one strain (K20)
increased from about 85% in growing VH25 cells to about 95%
in K20 cells at PD 300, which may be one explanation for the
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Table 1
Properties of eight h-TERT immortalised fibroblasts clones
Group Cell PD PD/week Ploidy p16INK4a Irradiation response after 6 Gy
p53 p21WAF-1,CIP-1 Survival (%)
WT VH25 45 2.5 2n wt wt wt 0.8
A K21 470 3.6 2n up/wt wt wt 2.0
K22 380 3.8 2n ND wt wt 0.3
K25 320 3.1 2n ND wt wt 1.0
K26 320 3.6 2n up/wt wt(+) wt 1.0
B K15 320 3.4 2n up/wt +  10.3
K20 330 5.2 4n ND +  20.0
K23 260 3.8 2n–4n wt +  12.4
C K19 290 2.6 4n ND wt wt 0.1
The cells were immortalised by transfection at PD 23 with pGRN145 (Geron Corp., Menlo Park, USA). The parent line VH25 has a maximal number of 45 PDs before
it senesces. In the immortalised clones, PD indicates the population doubling number reached at the end of our experiment. Growth rate (PD/week), ploidy and cell
cycle checkpoint controls are shown at the indicated PD. Four clones (Group A) still retained their wild type characteristics while three clones (Group B) developed
changes in (radiation induced) cell cycle control with or without tetraploidy. Tetraploidy without cell cycle control changes was detected in only one clone (Group C).
Ploidy was tested by FACS analysis and survival after 6 Gy of g-rays was assayed using the clonogenic assay (Kampinga et al., 2004).observed increase in growth rate of the cultures. The increasing
growth rate during prolonged culture did not result in loss of
contact inhibition in any of the eight clones as determined by
the soft agar assay (data not shown).
Our analysis reveals that three cell lines show an increase in
constitutive p53 expression paralleled by a loss in constitutive
and radiation-inducible p21WAF-1,CIP-1 expression (Fig. 1;
Group B). It may be possible that due to the absence of
p21WAF-1,CIP-1 these cells allow elevated expression of p53
without inducing cell cycle arrest. This may also explain the
reduced radiosensitivity as was demonstrated with the
clonogenic cell survival assay. Alternatively, p53 overexpres-
sion may be caused by mutations in the p53 gene locus,Fig. 1. Western blotting of p53, p21WAF-1,CIP-1 and p16INK4a in hTERT-immortalised
non-transfected cells (VH25) and the three groups A–C of the immortalised fibroblas
the wild type characteristics. In Group B, the cells developed abnormalities in cell cy
developed tetraploidy only. The method used is as described in Kampinga et al. (2004
Santa Cruz, USA and p21WAF-1 antibody (AB-1) of Oncogene, Amsterdam, The Neth
MO, USA) was used to monitor loading variation.rendering the genes inactive, as occurs in many cancers (Soussi
and Lozano, 2005). The presence of tetraploidy by itself seems
to have no effect on radiosensitivity as was demonstrated in
K19 (Table 1).
The increase in p53 expression may be due to stress caused
by DNA damage during prolonged culture and in normal,
p21WAF-1,CIP-1-expressing populations these cells would have
been eliminated by growth-arrest (Ben Porath and Weinberg,
2005; Campisi, 2005). Due to the inability to express p21WAF-
1,CIP-1 these cells can now enter mitosis with unrepaired DNA
giving rise to genomic instability which in turn may lead to a
transformed phenotype. Such cells will have a growth
advantage and will take over the population.fibroblasts, non-irradiated (0 Gy) and 6 h after g-irradiation (6 Gy). Shown are
ts at the indicated PD-number. Group A represents the clones which still retained
cle control parameters, either with or without tetraploidy. The clone in Group C
) using the p53 (DO-1) and p16 (C-20) antibodies of Santa Cruz Biotechnology,
erlands. Detection of g-tubulin (by g-tubulin antibody T6557, Sigma, St. Louis,
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Fig. 2. Growth curves of hTERT immortalised fibroblasts: Group A (thin lines)
still shows wild type characteristics; Group B (thick lines) started showing
abnormalities in cell cycle control after 150–300 PDs with or without devel-
oping tetraploidy; Group C (dashed line) is tetraploid only. The wild type cells
(VH25) stopped growing at 45 PD.The p16INK4a expression level in the primary foreskin
fibroblasts (VH25) is low. In some of the immortalised clones, it
increased initially after the hTERT insertion, but after
prolonged culture it decreased to levels comparable to the
wild type (Fig. 1). No correlation of p16INK4a levels was
observed with the development of abnormalities in the other
cell cycle parameters or ploidy. It is of note that in all clones
p16INK4a is reduced at the later PDs. This may imply a reduction
in stress induced cell cycle arrest.
Changes in cell cycle parameters after immortalisation with
hTERT were reported by others as well. Noble et al. (2004)
observed a mutation of the p53 gene in one out of three immortal
clones. Expression of p16INK4a was found to be elevated after
immortalisationbut gradually disappearedduring the accelerated
growth phase (Milyavsky et al., 2003; Noble et al., 2004). Our
data for eight independent clones extend the observation that
after prolonged growth, a culture is being overtaken by cells
which have a growth advantage due to altered p53 or p16INK4a
responses. These altered responses prevent the cells from
entering cell cycle arrest when they experience stress, such as
nutrient deprivation or oxidative damage (Ben Porath and
Weinberg, 2005; Campisi, 2005). Selection for these altered
responses is a stochastic process, whichwill partly depend on the
level of experienced stress during culturing, and thismay explain
why in some cultures these changes occur shortly after
immortalisation and why other cultures appear normal even
after several hundreds of PDs.
It is now clear that, while initially it was believed that
hTERT immortalised cells maintain a normal phenotype(Bodnar et al., 1998; Jiang et al., 1999; Morales et al., 1999;
Nakamura et al., 2002), prolonged culturing will lead to cells
with abnormal behaviour (Milyavsky et al., 2003; Noble et al.,
2004; this work). Although immortalising fibroblasts by
reconstitution of active telomerase can be a reliable manner
to generate a large number of cells similar to primary cells,
monitoring these cells remains important, since during
continuous growth cells with altered characteristics can
overtake the culture. For this reason, the use of hTERT for
the immortalisation of cells for in vivo use needs to be
considered with great caution.
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